• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制组蛋白甲基转移酶、组蛋白去乙酰化酶和β-连环蛋白可协同增强骨髓细胞的心脏潜能。

Inhibition of Histone Methyltransferase, Histone Deacetylase, and -Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells.

作者信息

Yang Jinpu, Kaur Keerat, Edwards John G, Eisenberg Carol A, Eisenberg Leonard M

机构信息

New York Medical College/Westchester Medical Center Stem Cell Laboratory, Departments of Physiology and Medicine, New York Medical College, Valhalla, NY 10595, USA.

Department of Biology and Genomics, New York University, New York, NY 10003, USA.

出版信息

Stem Cells Int. 2017;2017:3464953. doi: 10.1155/2017/3464953. Epub 2017 Jul 16.

DOI:10.1155/2017/3464953
PMID:28791052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5534312/
Abstract

Previously, we reported that treatment with the G9a histone methyltransferase inhibitor BIX01294 causes bone marrow mesenchymal stem cells (MSCs) to exhibit a cardiocompetent phenotype, as indicated by the induction of the precardiac markers Mesp1 and brachyury. Here, we report that combining the histone deacetylase inhibitor trichostatin A (TSA) with BIX01294 synergistically enhances MSC cardiogenesis. Although TSA by itself had no effect on cardiac gene expression, coaddition of TSA to MSC cultures enhanced BIX01294-induced levels of Mesp1 and brachyury expression 5.6- and 7.2-fold. Moreover, MSCs exposed to the cardiogenic stimulus Wnt11 generated 2.6- to 5.6-fold higher levels of the cardiomyocyte markers GATA4, Nkx2.5, and myocardin when pretreated with TSA in addition to BIX01294. MSC cultures also showed a corresponding increase in the prevalence of sarcomeric protein-positive cells when treated with these small molecule inhibitors. These results correlated with data showing synergism between (1) TSA and BIX01294 in promoting acetylation of lysine 27 on histone H3 and (2) BIX01294 and Wnt11 in decreasing -catenin accumulation in MSCs. The implications of these findings are discussed in light of observations in the early embryo on the importance of -catenin signaling and histone modifications for cardiomyocyte differentiation and heart development.

摘要

此前,我们报道过,使用G9a组蛋白甲基转移酶抑制剂BIX01294进行处理会使骨髓间充质干细胞(MSC)呈现心脏祖细胞表型,这可通过心脏前体细胞标志物Mesp1和短尾相关蛋白的诱导表达来表明。在此,我们报道,将组蛋白去乙酰化酶抑制剂曲古抑菌素A(TSA)与BIX01294联合使用可协同增强MSC向心肌细胞的分化。尽管TSA单独使用时对心脏基因表达没有影响,但在MSC培养物中同时添加TSA可使BIX01294诱导的Mesp1和短尾相关蛋白表达水平分别提高5.6倍和7.2倍。此外,当除了BIX01294之外还用TSA进行预处理时,暴露于心脏发生刺激因子Wnt11的MSC产生的心肌细胞标志物GATA4、Nkx2.5和心肌转录因子的水平要高出2.6至5.6倍。在用这些小分子抑制剂处理时,MSC培养物中肌节蛋白阳性细胞的比例也相应增加。这些结果与以下数据相关:(1)TSA和BIX01294在促进组蛋白H3赖氨酸27乙酰化方面具有协同作用;(2)BIX01294和Wnt11在降低MSC中β-连环蛋白积累方面具有协同作用。结合早期胚胎中关于β-连环蛋白信号传导和组蛋白修饰对心肌细胞分化和心脏发育的重要性的观察结果,对这些发现的意义进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/e74db0e7e702/SCI2017-3464953.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2f2d2cc0a38a/SCI2017-3464953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2f017b983b50/SCI2017-3464953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/32985be1e578/SCI2017-3464953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/f4ee62c7ab4a/SCI2017-3464953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/60c5e3d0fb7c/SCI2017-3464953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2c98d5fd293a/SCI2017-3464953.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/a2594ef2afd1/SCI2017-3464953.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/73427ab05dcc/SCI2017-3464953.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/6004ec2f454c/SCI2017-3464953.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/e74db0e7e702/SCI2017-3464953.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2f2d2cc0a38a/SCI2017-3464953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2f017b983b50/SCI2017-3464953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/32985be1e578/SCI2017-3464953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/f4ee62c7ab4a/SCI2017-3464953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/60c5e3d0fb7c/SCI2017-3464953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/2c98d5fd293a/SCI2017-3464953.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/a2594ef2afd1/SCI2017-3464953.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/73427ab05dcc/SCI2017-3464953.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/6004ec2f454c/SCI2017-3464953.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/5534312/e74db0e7e702/SCI2017-3464953.010.jpg

相似文献

1
Inhibition of Histone Methyltransferase, Histone Deacetylase, and -Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells.抑制组蛋白甲基转移酶、组蛋白去乙酰化酶和β-连环蛋白可协同增强骨髓细胞的心脏潜能。
Stem Cells Int. 2017;2017:3464953. doi: 10.1155/2017/3464953. Epub 2017 Jul 16.
2
Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent Progenitors.抑制G9a组蛋白甲基转移酶可将骨髓间充质干细胞转化为具有心脏分化能力的祖细胞。
Stem Cells Int. 2015;2015:270428. doi: 10.1155/2015/270428. Epub 2015 May 21.
3
The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells.组蛋白甲基转移酶抑制剂 BIX01294 增强骨髓细胞的心脏潜能。
Stem Cells Dev. 2013 Feb 15;22(4):654-67. doi: 10.1089/scd.2012.0181. Epub 2012 Nov 7.
4
G9a histone methyltransferase inhibitor BIX01294 promotes expansion of adult cardiac progenitor cells without changing their phenotype or differentiation potential.G9a组蛋白甲基转移酶抑制剂BIX01294可促进成年心脏祖细胞的扩增,而不改变其表型或分化潜能。
Cell Prolif. 2016 Jun;49(3):373-85. doi: 10.1111/cpr.12255. Epub 2016 Apr 24.
5
Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.曲古抑菌素 A 通过一种不依赖于组蛋白去乙酰化酶抑制的机制促进 5-氮杂胞苷诱导或与新生大鼠心肌细胞共培养后的大鼠间充质干细胞的心肌细胞分化。
Cell Transplant. 2012;21(5):985-96. doi: 10.3727/096368911X593145. Epub 2011 Sep 22.
6
G9a inhibition promotes neuronal differentiation of human bone marrow mesenchymal stem cells through the transcriptional induction of RE-1 containing neuronal specific genes.G9a抑制通过含RE-1的神经元特异性基因的转录诱导促进人骨髓间充质干细胞的神经元分化。
Neurochem Int. 2016 Jun;96:77-83. doi: 10.1016/j.neuint.2016.03.002. Epub 2016 Mar 4.
7
Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.G9a抑制剂BIX-01294作用于U251胶质瘤细胞的机制。
Mol Med Rep. 2016 Nov;14(5):4613-4621. doi: 10.3892/mmr.2016.5815. Epub 2016 Oct 6.
8
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide.用组蛋白甲基转移酶G9a抑制剂BIX01294对人胶质瘤细胞进行预处理或后处理,可使细胞对替莫唑胺敏感。
Front Pharmacol. 2018 Nov 2;9:1271. doi: 10.3389/fphar.2018.01271. eCollection 2018.
9
The effect of histone deacetylase inhibitor trichostatin A on porcine mesenchymal stem cell transcriptome.组蛋白去乙酰化酶抑制剂曲古抑菌素A对猪间充质干细胞转录组的影响
Biochimie. 2017 Aug;139:56-73. doi: 10.1016/j.biochi.2017.05.015. Epub 2017 May 25.
10
Histone modifications interact with DNA methylation at the GATA4 promoter during differentiation of mesenchymal stem cells into cardiomyocyte-like cells.在间充质干细胞分化为心肌样细胞的过程中,组蛋白修饰与GATA4启动子处的DNA甲基化相互作用。
Cell Prolif. 2016 Jun;49(3):315-29. doi: 10.1111/cpr.12253. Epub 2016 Apr 26.

引用本文的文献

1
Stem Cells Associated with Adult Skeletal Muscle Can Form Beating Cardiac Tissue In Vitro in Response to Media Containing Heparin, Dexamethasone, Growth Factors and Hydrogen Peroxide.与成年骨骼肌相关的干细胞在含有肝素、地塞米松、生长因子和过氧化氢的培养基作用下可在体外形成跳动的心脏组织。
Int J Mol Sci. 2025 Mar 17;26(6):2683. doi: 10.3390/ijms26062683.
2
G9a inhibition promotes the formation of pacemaker-like cells by reducing the enrichment of H3K9me2 in the HCN4 promoter region.G9a 抑制通过减少 HCN4 启动子区域中 H3K9me2 的富集促进起搏样细胞的形成。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2022.12908. Epub 2022 Dec 9.
3

本文引用的文献

1
From Bone Marrow to Cardiac Atrial Appendage Stem Cells for Cardiac Repair: A Review.从骨髓到心脏心耳干细胞用于心脏修复:综述
Curr Med Chem. 2016;23(23):2421-38. doi: 10.2174/0929867323666160525114735.
2
Cell-based multi-substrate assay coupled to UHPLC-ESI-MS/MS for a quick identification of class-specific HDAC inhibitors.基于细胞的多底物分析与超高效液相色谱-电喷雾串联质谱联用,用于快速鉴定特定类别的组蛋白去乙酰化酶抑制剂。
J Enzyme Inhib Med Chem. 2016;31(sup1):209-214. doi: 10.1080/14756366.2016.1180595. Epub 2016 May 5.
3
Conversion of human fibroblasts into functional cardiomyocytes by small molecules.
Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan.
衰老和寿命调控中的乙酰辅酶A代谢与组蛋白乙酰化
Antioxidants (Basel). 2021 Apr 8;10(4):572. doi: 10.3390/antiox10040572.
4
The combination of G9a histone methyltransferase inhibitors with erythropoietin protects heart against damage from acute myocardial infarction.G9a组蛋白甲基转移酶抑制剂与促红细胞生成素联合使用可保护心脏免受急性心肌梗死的损伤。
Am J Transl Res. 2020 Jul 15;12(7):3255-3271. eCollection 2020.
小分子将人成纤维细胞转化为功能性心肌细胞。
Science. 2016 Jun 3;352(6290):1216-20. doi: 10.1126/science.aaf1502. Epub 2016 Apr 28.
4
G9a histone methyltransferase inhibitor BIX01294 promotes expansion of adult cardiac progenitor cells without changing their phenotype or differentiation potential.G9a组蛋白甲基转移酶抑制剂BIX01294可促进成年心脏祖细胞的扩增,而不改变其表型或分化潜能。
Cell Prolif. 2016 Jun;49(3):373-85. doi: 10.1111/cpr.12255. Epub 2016 Apr 24.
5
Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology.在猪缺血性心肌病中通过非闭塞性三血管冠状动脉内输注实现心脏来源干细胞的广泛心肌递送:磁共振成像和组织学证明不良重塑的显著减轻
PLoS One. 2016 Jan 19;11(1):e0144523. doi: 10.1371/journal.pone.0144523. eCollection 2016.
6
Wnt signaling in the heart fields: Variations on a common theme.心脏区域中的Wnt信号传导:同一主题的变体
Dev Dyn. 2016 Mar;245(3):294-306. doi: 10.1002/dvdy.24372. Epub 2016 Jan 6.
7
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair.人胚胎干细胞衍生的心肌细胞、心血管祖细胞和骨髓单核细胞在心脏修复中的比较。
Stem Cell Reports. 2015 Nov 10;5(5):753-762. doi: 10.1016/j.stemcr.2015.09.011.
8
Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT.在一项注册研究中,重复冠状动脉内注射骨髓源细胞改善了预后:随机结局试验REPEAT的理论依据。
Eur Heart J. 2016 Jun 1;37(21):1659-66. doi: 10.1093/eurheartj/ehv559. Epub 2015 Oct 29.
9
Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.人诱导多能干细胞衍生心肌细胞构建的组织工程心脏补片在大鼠梗死模型中的功能效应
Stem Cells Transl Med. 2015 Nov;4(11):1324-32. doi: 10.5966/sctm.2015-0044. Epub 2015 Sep 14.
10
Cardiac Regeneration and Stem Cells.心脏再生与干细胞
Physiol Rev. 2015 Oct;95(4):1189-204. doi: 10.1152/physrev.00021.2014.